MMC.Marsh & Mclennan Companies, INC

Form 4: Marsh & McLennan CFO Exercises Stock Options and Sells Shares

Sentiment:

SEC Form 4 Filing

📋All filings for Marsh & Mclennan Companies, INC
🔒Login to Follow

Mark C. McGivney, CFO of Marsh & McLennan Companies, exercised stock options and sold shares on August 22, 2024, according to a Form 4 filing with the SEC.

Summary

  • On August 22, 2024, Mark C. McGivney, the Chief Financial Officer of Marsh & McLennan Companies, exercised stock options to acquire 50,928 shares of common stock at a price of $118.865 per share.
  • Simultaneously, McGivney sold 50,928 shares of common stock at a weighted average price of $225.2224, with individual sales ranging from $225 to $225.580.
  • Following these transactions, McGivney directly owns 33,678 shares of Marsh & McLennan Companies.
  • The stock option exercise was related to options granted on February 19, 2020, which vested in four equal annual installments.
  • The sale of shares was conducted under a pre-arranged Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reflects a routine transaction under a pre-arranged trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's value and future prospects. Rule 10b5-1 plans are frequently used to allow insiders to sell shares without being accused of acting on non-public information.

Comparison to Industry Standards

  • Marsh & McLennan is a global professional services firm, and executive compensation practices are generally in line with those of its peers such as Aon, Willis Towers Watson, and Arthur J. Gallagher & Co.
  • Stock option grants and sales are a standard component of executive compensation packages in these firms.
  • The use of Rule 10b5-1 trading plans is also a common practice among executives in these companies to manage their stock holdings.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders as it is a routine sale of shares by an executive under a pre-arranged plan.
  • The market may interpret the sale as a neutral signal, given the use of the Rule 10b5-1 plan.

Key Dates

DateDescription
02/19/2020Stock options were granted.
02/19/2021First vesting date of stock options.
02/19/2022Second vesting date of stock options.
02/19/2023Third vesting date of stock options.
02/19/2024Fourth vesting date of stock options.
08/22/2024Date of stock option exercise and share sale.
08/26/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.